{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:45:51Z","timestamp":1792658751528,"version":"4.5.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,28]]},"DOI":"10.1097\/qad.0b013e32833407d3","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T05:43:18Z","timestamp":1263879798000},"page":"331-340","source":"Crossref","is-referenced-by-count":36,"title":["Medication-assisted treatment and HIV\/AIDS: aspects in treating HIV-infected drug users"],"prefix":"10.1097","volume":"24","author":[{"given":"R Douglas","family":"Bruce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Kresina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinore F","family":"McCance-Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1037\/0893-164X.21.3.365","article-title":"Alcohol use, expectancies, and sexual sensation seeking as correlates of HIV risk behavior in heterosexual young adults","volume":"21","author":"Hendershot","year":"2007","journal-title":"Psychol Addict Behav"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1468-1293.2008.00545.x","article-title":"Alcohol use among HIV-infected persons in care: results of a multisite survey","volume":"9","author":"Chander","year":"2008","journal-title":"HIV Medicine"},{"issue":"Suppl","key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1748-0361.2007.00127.x","article-title":"Stimulant use and sexual risk behaviors for HIV in rural North Carolina","volume":"23","author":"Zule","year":"2007","journal-title":"J Rural Health"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09540120701561270","article-title":"Drug sharing with clients as a risk factor for increased violence and sexual and drug related harms among survival sex workers","volume":"20","author":"Shannon","year":"2008","journal-title":"AIDS Care"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.idc.2007.03.009","article-title":"Clinical care of the HIV-infected drug user","volume":"21","author":"Bruce","year":"2007","journal-title":"Infect Dis Clin N America"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jurban\/jth153","article-title":"Co-occurring hepatitis C, substance use and psychiatric illness: treatment issues and developing integrated models of care","volume":"81","author":"Sylvestre","year":"2004","journal-title":"J Urban Health"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(99)00104-0","article-title":"Drug abuse treatment as an HIV prevention strategy: a review","volume":"59","author":"Sorensen","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/500200","article-title":"Models of integrating buprenorphine therapy into HIV care","volume":"42","author":"Basu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMcp013579","article-title":"Clinical practice. Office-based treatment of opioid-dependent patients","volume":"347","author":"Fiellin","year":"2002","journal-title":"N Engl J Med"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0022-3565(25)33173-3","article-title":"The affinity of morphine for its pharmacologic receptor in vivo","volume":"222","author":"Tallarida","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1530-0277.2007.00343.x","article-title":"What role does the measuring medication compliance play in evaluating the efficacy of naltrexone?","volume":"31","author":"Baros","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0376-8716(83)90042-X","article-title":"Predictors of favorable outcome following naltrexone treatment","volume":"12","author":"Greenstein","year":"1983","journal-title":"Drug Alcohol Depend"},{"key":"R19-3-20210130","first-page":"67","article-title":"Illicit drugs, alcohol and addiction in human immunodeficiency virus","volume":"49","author":"Samet","year":"2007","journal-title":"Panminerva Medicine"},{"issue":"Suppl 1","key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.jcp.0000248604.58305.b3","article-title":"Combining psychosocial treatment with pharmacotherapy for alcohol dependence","volume":"26","author":"Weiss","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.jcp.0000222512.25649.08","article-title":"The status of disulfiram: a half of a century later","volume":"26","author":"Suh","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0197-2456(84)90030-8","article-title":"Veterans Administration cooperative study of disulfiram in the treatment of alcoholism: study design and methodological considerations","volume":"5","author":"Fuller","year":"1984","journal-title":"Control Clin Trials"},{"key":"R24-3-20210130","first-page":"1212","article-title":"Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation","volume":"22","author":"Madan","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"R25-3-20210130","first-page":"217","article-title":"Advances in the use of naltrexone: an integration of preclinical and clinical findings","volume":"16","author":"O'Malley","year":"2003","journal-title":"Rec Dev Alcohol"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11920-006-0040-0","article-title":"Choosing the right medication for the treatment of alcoholism","volume":"8","author":"Patinati","year":"2006","journal-title":"Curr Psychiatry Rep"},{"issue":"Suppl 20","key":"R27-3-20210130","first-page":"42","article-title":"Treatment of alcohol-dependent outpatients with acamprosate: a clinical review","volume":"62","author":"Mason","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1089\/apc.2007.9985","article-title":"Type and pattern of illicit drug use and access to healthcare services for HIV-infected people","volume":"21","author":"Sohler","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"R30-3-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00004714-200204000-00017","article-title":"Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers","volume":"22","author":"Begre","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/dmd.31.6.742","article-title":"Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.qai.0000219769.89679.ec","article-title":"Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice","volume":"41","author":"Bruce","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-3-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00042560-199808150-00004","article-title":"Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)","volume":"18","author":"McCance-Katz","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R34-3-20210130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1521-0391.2001.tb00519.x","article-title":"Effect of opioid dependence pharmacotherapies on zidovudine disposition","volume":"10","author":"McCance-Katz","year":"2001","journal-title":"Am J Addict"},{"key":"R35-3-20210130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00126334-200007010-00008","article-title":"Interaction of methadone with didanosine and stavudine","volume":"24","author":"Rainey","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-3-20210130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/10550490252801657","article-title":"The pharmacokinetics of methadone following co-administration with a lamivudine\/zidovudine combination tablet in opiate-dependent subjects","volume":"11","author":"Rainey","year":"2002","journal-title":"Am J Addict"},{"key":"R38-3-20210130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00002030-199905280-00012","article-title":"Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone","volume":"13","author":"Altice","year":"1999","journal-title":"AIDS"},{"key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1086\/322519","article-title":"Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users","volume":"33","author":"Clarke","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R40-3-20210130","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1128\/AAC.48.11.4148-4153.2004","article-title":"Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients","volume":"48","author":"Stocker","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2125.2001.00342.x","article-title":"The pharmacokinetics of methadone in HIV-positive patients receiving the nonnucleoside reverse transcriptase inhibitor efavirenz","volume":"51","author":"Clarke","year":"2001","journal-title":"Br J Clin Pharm"},{"key":"R42-3-20210130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1345\/aph.19156","article-title":"Methadone withdrawal symptoms with nevirapine and efavirenz","volume":"34","author":"Pinzani","year":"2000","journal-title":"Ann Pharmacother"},{"key":"R44-3-20210130","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1086\/508186","article-title":"Pharmacokinetic interactions between buprenorphine and antiretroviral medications","volume":"43","author":"Bruce","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R45-3-20210130","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/508187","article-title":"Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R46-3-20210130","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1086\/508188","article-title":"Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir\/ritonavir, and ritonavir","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R47-3-20210130","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJM197605132942008","article-title":"Rifampin-induced methadone withdrawal","volume":"294","author":"Kreek","year":"1976","journal-title":"N Engl J Med"},{"key":"R48-3-20210130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0009-9236(98)90089-3","article-title":"The effect of fluconazole on the clinical pharmacokinetics of methadone","volume":"63","author":"Cobb","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R49-3-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinthera.2007.01.009","article-title":"Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment","volume":"29","author":"Berk","year":"2007","journal-title":"Clin Ther"},{"key":"R52-3-20210130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.aids.0000216384.22432.9a","article-title":"Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir","volume":"20","author":"Bruce","year":"2006","journal-title":"AIDS"},{"key":"R53-3-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drugalcdep.2007.06.007","article-title":"Interaction between buprenorphine and atazanavir or atazanavir\/ritonavir","volume":"91","author":"McCance-Katz","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R54-3-20210130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2009.07.007","article-title":"Pharmacokinetic interactions between buprenorphine\/naloxone and tipranavir\/ritonavir in HIV-negative subjects chronically receiving buprenorphine\/naloxone","volume":"105","author":"Bruce","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R55-3-20210130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/08892220260139495","article-title":"Alcohol use and HIV pharmacotherapy","volume":"18","author":"Kresina","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R56-3-20210130","first-page":"5","article-title":"The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants","volume":"30","author":"Edenberg","year":"2007","journal-title":"Alcohol Res Health"},{"key":"R57-3-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/108729101300003636","article-title":"Alcohol use can result in enhanced drug metabolism in HIV pharmacotherapy","volume":"15","author":"Flexner","year":"2001","journal-title":"AIDS Patient Care STDS"},{"key":"R58-3-20210130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.44.6.1686-1690.2000","article-title":"Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults","volume":"44","author":"McDowell","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R59-3-20210130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.mcg.0000173929.60115.b4","article-title":"Drug-induced pancreatitis: an update","volume":"39","author":"Trivedi","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R60-3-20210130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/dkh555","article-title":"Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy","volume":"55","author":"Pineda","year":"2005","journal-title":"J Antimicrobl Chemother"},{"key":"R61-3-20210130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/17512433.1.1.115","article-title":"Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practice","volume":"1","author":"Bruce","year":"2008","journal-title":"Exp Rev Clin Pharm"},{"key":"R62-3-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.psy.46.1.79","article-title":"Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse","volume":"46","author":"Wynn","year":"2005","journal-title":"Psychosomatics"},{"key":"R63-3-20210130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"R64-3-20210130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127009903901102","article-title":"Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam","volume":"39","author":"Yuan","year":"1999","journal-title":"J Clin Pharm"},{"key":"R65-3-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00003088-200140030-00005","article-title":"Delavirdine: clinical pharmacokinetics and drug interactions","volume":"40","author":"Tran","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R66-3-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00003088-199835040-00002","article-title":"Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents","volume":"35","author":"Hsu","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"R67-3-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002018-199818020-00001","article-title":"Systemic antifungal agents. Drug interactions of clinical significance","volume":"18","author":"Albengres","year":"1998","journal-title":"Drug Safety"},{"key":"R68-3-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00003088-200544100-00003","article-title":"Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir","volume":"44","author":"Le Tiec","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R69-3-20210130","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/1078-0432.CCR-05-0703","article-title":"Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes","volume":"11","author":"Yong","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R70-3-20210130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0076-6879(05)00007-8","article-title":"Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases","volume":"400","author":"Court","year":"2005","journal-title":"Methods Enzymol"},{"issue":"Suppl 4","key":"R72-3-20210130","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/508183","article-title":"Initial strategies for integrating buprenorphine into HIV care settings in the United States","volume":"43","author":"Sullivan","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R73-3-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11908-009-0011-9","article-title":"Changes in the clinical epidemiology of HIV infection in the United States: implications for the clinician","volume":"11","author":"Buchacz","year":"2009","journal-title":"Curr Infect Dis Rep"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e32833407d3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T20:51:11Z","timestamp":1739739071000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201001280-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833407d3","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1,28]]}}}